Constellation Software Inc. (TSX:CSU) BUY
Constellation Software is one of the world's best capital allocators — a serial acquirer of niche software businesses — and after a 45 per cent drawdown it trades at about fourteen to fifteen times cash earnings, with a very low PEG. A quality compounder on sale, on a strong-buy Street. A BUY.
Re-presenting the Donatien Investment report on Constellation Software (TSX:CSU), dated 6 July 2026, at C$2,757. BUY across all horizons.
An elite capital allocator
Constellation buys dozens of small, mission-critical software companies every year at disciplined prices, run through a highly decentralised structure, and compounds the cash they throw off into more acquisitions. Its track record of high returns on invested capital is legendary, and it keeps unlocking value through spin-offs like Topicus and Lumine. This is one of the best capital-allocation machines in public markets, diversified across thousands of sticky software niches.
Cheap on cash earnings
Here's the opportunity. The trailing GAAP price-to-earnings looks high near fifty-five times, but that's distorted by acquired-intangible amortisation, a non-cash charge inherent to the acquisitive model. On the cash earnings the business actually generates, the multiple is about fourteen to fifteen times, with a PEG of just over a half — genuinely cheap for a twenty-per-cent compounder, especially after a forty-five per cent drawdown. The Street is strong-buy with roughly forty-five per cent upside to consensus.
What to watch
The main risk isn't a competitor — it's size. As Constellation gets bigger, it must deploy ever more capital at the high returns that made it great, and rising deal multiples make that harder. It has managed this for years, but it's the metric to watch. The shares are also still basing after the drawdown, so the tape hasn't confirmed a new uptrend yet.
What could go wrong
Capital-deployment returns compress as size grows. A broad, lasting software-multiple de-rating. Still basing after the -45% drawdown.
Risk vs Reward
The report weights three twelve-month paths with a positive skew. The base case — most likely at 55 per cent — sees Constellation around C$3,800 as compounding continues and the cash multiple partly re-rates toward the analyst consensus, about 38 per cent above today. The bull case at 25 per cent reaches C$4,700 if deployment returns hold and spin-off optionality is recognised. The bear at 20 per cent takes it to C$2,200 if returns compress or software de-rates — a retest of the low.
The verdict
The bottom line: one of the world's best capital allocators, on sale. At about fourteen to fifteen times cash earnings after a forty-five per cent drawdown, with a strong-buy Street behind it, this is a quality-on-sale BUY. It's not a strong buy only because the driver and economy are merely neutral and the tape is still basing — so scale in on weakness rather than chase, and watch deployment returns as the business grows.
Read the full report on donatien.ca →
